Christine N. Sang, M.D., M.P.H.

Education

M.D., Johns Hopkins University, Baltimore, Maryland, 1989
M.S., Public Health, Harvard University, Cambridge, Massachusetts

Residency

Anesthesiology, Children’s Hospital, Boston, Massachusetts, 1992

Fellowship

Pediatric Anesthesia, Children’s Hospital, Boston, Massachusetts, 1993
Anesthesia, Harvard School of Public Health, Boston, Massachusetts, 1994

Board Certifications

American Board of Anesthesiology
American Board of Anesthesiology, Pain Management

Hospital Affiliations/Admitting Privileges

Brigham and Women’s Hospital
Children’s Hospital Boston

Dr. Sang is a pain specialist and anesthesiologist whose well-funded clinical lab conducts important research into novel analgesics to target specific mechanisms of pain.

She received her medical degree from Johns Hopkins University in Baltimore, and also earned a Master of Public Health from Harvard University. After completing her internship in pediatrics at Children’s Hospital of Philadelphia, and a residency in anesthesiology at Johns Hopkins Hospital, she continued her medical training at Harvard Medical School and the National Institutes of Health in Bethesda, Maryland. At the National Institutes of Health Clinical Center, she was the Associate Medical Director of the Pain Research Clinic. Prior to heading the Translational Pain Research Program at the Brigham and Women’s Hospital, Dr. Sang served as the Director of the Clinical Trials Program at the Massachusetts General Hospital Pain Center.

Dr. Sang serves on the Board of Directors of the American Pain Society, and is a founding member and steering committee member of the Neuropathic Pain Institute. She has been selected as a member of numerous national and international steering committees and scientific advisory boards for professional societies and pharmaceutical companies. In addition, she has organized and participated in consensus conferences in neuropathic pain, neurofibromatosis, and spinal cord injury.

Dr. Sang’s clinical lab is funded by competitive private funding sources, including the Paralyzed Veterans of America and the Christopher Reeve Paralysis Foundation, as well as the National Institutes of Health. In addition to the research conducted in her own lab, Dr. Sang is an active consultant in the discovery and clinical development of novel analgesics, clinical trial design, and pain management of central and peripheral neuropathic syndromes.